Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform
- Written by PR Newswire Asia - Daily Bulletin Au RSS
Authors: PR Newswire Asia - Daily Bulletin Au RSS
Read more http://www.prnasia.com/story/archive/4934715_CN34715_0




